DOI: 10.1055/s-00000069

Seminars in Liver Disease

Ausgabe 02 · Volume 41 · Mai 2021 DOI: 10.1055/s-011-51103

Review Article

109
Marcellin, Fabienne; Jaquet, Antoine; Lazarus, Jeffrey V.; Molina, Patricia; Carrieri, Patrizia: Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play
117
Yao, Francis Y.; Fidelman, Nicholas; Mehta, Neil: The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma
128
Dunn, Michael A.; Kappus, Matthew R.; Bloomer, Pamela M.; Duarte-Rojo, Andres; Josbeno, Deborah A.; Jakicic, John M.: Wearables, Physical Activity, and Exercise Testing in Liver Disease
136
Uson Junior, Pedro Luiz Serrano; Nagalo, Bolni Marius; Ahn, Daniel H.; Bekaii-Saab, Tanios; Borad, Mitesh J.: Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?
142
Sekiba, Kazuma; Otsuka, Motoyuki; Koike, Kazuhiko: Potential of HBx Gene for Hepatocarcinogenesis in Noncirrhotic Liver
150
Kaufmann, Benedikt; Reca, Agustina; Kim, Andrea D.; Feldstein, Ariel E.: Novel Mechanisms for Resolution of Liver Inflammation: Therapeutic Implications
163
Ortiz, Vivian; Ellenberg, Susan S.; Weinberg, Ethan M.: Blinding in Clinical Trials for Chronic Liver Diseases
172
Moeckli, Beat; Majno, Pietro; Orci, Lorenzo A.; Peloso, Andrea; Toso, Christian: Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective
182
Lee, Hye Won; Ahn, Sang Hoon; Chan, Henry Lik-Yuen: Hepatitis B Core-Related Antigen: From Virology to Clinical Application
191
Gil-Gómez, Antonio; Brescia, Paola; Rescigno, Maria; Romero-Gómez, Manuel: Gut–Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers
206
Soroka, Carol J.; Roberts, Scott J.; Boyer, James L.; Assis, David N.: Role of Biliary Organoids in Cholestasis Research and Regenerative Medicine
213
Haep, Nils; Florentino, Rodrigo M.; Squires, James E.; Bell, Aaron; Soto-Gutierrez, Alejandro: The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone